ACHV
Price
$4.26
Change
+$1.18 (+38.31%)
Updated
Oct 17, 11:49 AM (EDT)
Capitalization
157.4M
20 days until earnings call
Intraday Buy/Sell Signals
ATNM
Price
$1.48
Change
+$0.02 (+1.37%)
Updated
Oct 17, 11:41 AM (EDT)
Capitalization
45.55M
38 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

ACHV vs ATNM

Header iconACHV vs ATNM Comparison
Open Charts ACHV vs ATNMBanner chart's image
Achieve Life Sciences
Price$4.26
Change+$1.18 (+38.31%)
Volume$103.99K
Capitalization157.4M
Actinium Pharmaceuticals
Price$1.48
Change+$0.02 (+1.37%)
Volume$300
Capitalization45.55M
ACHV vs ATNM Comparison Chart in %
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACHV vs. ATNM commentary
Oct 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHV is a Hold and ATNM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 17, 2025
Stock price -- (ACHV: $3.08 vs. ATNM: $1.46)
Brand notoriety: ACHV and ATNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHV: 42% vs. ATNM: 151%
Market capitalization -- ACHV: $157.4M vs. ATNM: $45.55M
ACHV [@Biotechnology] is valued at $157.4M. ATNM’s [@Biotechnology] market capitalization is $45.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $104.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHV’s FA Score shows that 0 FA rating(s) are green whileATNM’s FA Score has 0 green FA rating(s).

  • ACHV’s FA Score: 0 green, 5 red.
  • ATNM’s FA Score: 0 green, 5 red.
According to our system of comparison, ACHV is a better buy in the long-term than ATNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHV’s TA Score shows that 4 TA indicator(s) are bullish while ATNM’s TA Score has 4 bullish TA indicator(s).

  • ACHV’s TA Score: 4 bullish, 5 bearish.
  • ATNM’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ACHV and ATNM are a bad buy in the short-term.

Price Growth

ACHV (@Biotechnology) experienced а -6.10% price change this week, while ATNM (@Biotechnology) price change was -2.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.58%. For the same industry, the average monthly price growth was +16.00%, and the average quarterly price growth was +79.29%.

Reported Earning Dates

ACHV is expected to report earnings on Nov 06, 2025.

ATNM is expected to report earnings on Nov 24, 2025.

Industries' Descriptions

@Biotechnology (+1.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACHV($157M) has a higher market cap than ATNM($45.5M). ATNM YTD gains are higher at: 15.873 vs. ACHV (-12.500). ATNM has higher annual earnings (EBITDA): -43.43M vs. ACHV (-49.25M). ATNM has more cash in the bank: 59.9M vs. ACHV (55.4M). ATNM has less debt than ACHV: ATNM (1.29M) vs ACHV (9.96M). ACHV (0) and ATNM (0) have equivalent revenues.
ACHVATNMACHV / ATNM
Capitalization157M45.5M345%
EBITDA-49.25M-43.43M113%
Gain YTD-12.50015.873-79%
P/E RatioN/AN/A-
Revenue00-
Total Cash55.4M59.9M92%
Total Debt9.96M1.29M772%
FUNDAMENTALS RATINGS
ACHV vs ATNM: Fundamental Ratings
ACHV
ATNM
OUTLOOK RATING
1..100
1255
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
63
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4657
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
650

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACHV's Valuation (44) in the Biotechnology industry is in the same range as ATNM (63). This means that ACHV’s stock grew similarly to ATNM’s over the last 12 months.

ACHV's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ATNM (100). This means that ACHV’s stock grew similarly to ATNM’s over the last 12 months.

ACHV's SMR Rating (100) in the Biotechnology industry is in the same range as ATNM (100). This means that ACHV’s stock grew similarly to ATNM’s over the last 12 months.

ACHV's Price Growth Rating (46) in the Biotechnology industry is in the same range as ATNM (57). This means that ACHV’s stock grew similarly to ATNM’s over the last 12 months.

ACHV's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ATNM (100). This means that ACHV’s stock grew similarly to ATNM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACHVATNM
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 19 days ago
72%
Declines
ODDS (%)
Bearish Trend 8 days ago
85%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KOTMF11.95N/A
N/A
Koito Manufacturing Co., Ltd.
TTNDF11.56N/A
N/A
Techtronic Industries Ltd.
AIUG2.10N/A
N/A
Lever Global Corporation
GAYMF0.52-0.07
-11.43%
Galway Metals Inc.
VYCO0.12-0.03
-19.81%
Vycor Medical, Inc.

ACHV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHV has been loosely correlated with ALT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ACHV jumps, then ALT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHV
1D Price
Change %
ACHV100%
-3.14%
ALT - ACHV
52%
Loosely correlated
-2.75%
ATNM - ACHV
39%
Loosely correlated
-5.81%
PLRX - ACHV
36%
Loosely correlated
+5.10%
NAUT - ACHV
33%
Loosely correlated
-2.73%
EYPT - ACHV
33%
Poorly correlated
-1.53%
More

ATNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATNM has been loosely correlated with CRBU. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNM jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATNM
1D Price
Change %
ATNM100%
-5.81%
CRBU - ATNM
44%
Loosely correlated
-5.99%
IPSC - ATNM
43%
Loosely correlated
-2.25%
RXRX - ATNM
42%
Loosely correlated
-6.33%
CRSP - ATNM
40%
Loosely correlated
-4.72%
ACHV - ATNM
39%
Loosely correlated
-3.14%
More